Successful treatment with secukinumab in a 4-month-old infant with severe generalized pustular psoriasis: a case report
Secukinumab may provide potential clinical benefits with an acceptable safety profile in infants with GPP. Further research is required to establish the optimal treatment duration, dosing intervals, and long-term safety in this population.
Authors
- Liang Zeng (ORCID: https://orcid.org/0000-0002-4517-7470)
- Li Chen (ORCID: https://orcid.org/0000-0003-4307-0896)
- Long Wang (ORCID: https://orcid.org/0000-0002-4905-9885)
- Yirong Li (ORCID: https://orcid.org/0000-0002-7493-045X)
- Lizhen Zhang (ORCID: https://orcid.org/0000-0002-3106-6825)
Institutions
- Guangdong Medical College (CN)
- Zhongshan People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-11-14
- DOI
- https://doi.org/10.3389/fmed.2025.1713628
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00